Gökbuget, N., Zugmaier, G., Klinger, M., Kufer, P., Stelljes, M., Viardot, A., . . . Bargou, R. (2017). Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia. Haematologica.
Stile di citazione ChicagoGökbuget, Nicola, et al. "Long-term Relapse-free Survival in a Phase 2 Study of Blinatumomab for the Treatment of Patients With Minimal Residual Disease in B-lineage Acute Lymphoblastic Leukemia." Haematologica 2017.
Citazione MLAGökbuget, Nicola, et al. "Long-term Relapse-free Survival in a Phase 2 Study of Blinatumomab for the Treatment of Patients With Minimal Residual Disease in B-lineage Acute Lymphoblastic Leukemia." Haematologica 2017.